Search filters

List of works by James S Blachly

A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.

scientific article published on 22 March 2018

A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome

scientific article published on 10 August 2020

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

scientific article published on 08 January 2020

Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years

scientific article published on 27 May 2020

BTKC481S-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

scientific article published on 13 February 2017

Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts

scientific article published on 02 October 2020

Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents

scientific article

Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib

Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21

scientific article published on 28 August 2019

Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations

scientific article published on 05 August 2020

Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically

scientific article published on 08 February 2019

Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib.

scientific article published in January 2015

Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia

scientific article published on 27 June 2016

Emerging drug profile: cyclin-dependent kinase inhibitors

scientific article published on 29 July 2013

Entospletinib in Combination With Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 expression

scientific article published on 20 August 2020

Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analyses.

scientific article

Expression and prognostic impact of lncRNAs in acute myeloid leukemia

scientific article

Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

scientific article published on 02 August 2019

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

scientific article published on 04 May 2021

Hairy cell leukemia: Update on molecular profiling and therapeutic advances

scientific article

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Implementation of standardized variant-calling nomenclature in the age of next-generation sequencing: where do we stand?

scientific article published on 24 January 2019

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies

scientific article published on 25 February 2018

Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality

scientific article published on 26 October 2016

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome

Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia

scientific article published on August 2016

Phase 2 study of ibrutinib in classic and variant hairy cell leukemia

scientific article published on 23 March 2021

Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia

scientific article published on 04 December 2020

PrEMeR-CG: inferring nucleotide level DNA methylation values from MethylCap-seq data

scientific article

Quality Control for RNA-Seq (QuaCRS): An Integrated Quality Control Pipeline

scientific article

Quantifying Hematopoietic Stem Cell Clonal Diversity by Selecting Informative Amplicon Barcodes

scientific article published on 07 February 2020

Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia

scientific article published on 03 November 2021

Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia

scientific article published on 26 November 2019

Ribosomal revelation

scientific article published in February 2016

Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia

scientific article published on 01 February 2019

Separating the wheat from the chaff in cHL.

scientific article published in February 2015

Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma.

scientific article published on 06 August 2014

The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia

scientific article

Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression

scientific article published on 04 November 2019

Paulina is supported by:

About Paulina

Help